Expert advice for hESC-based cell therapy development
Human embryonic stem (hES) cells have tremendous potential for treating humanity's currently incurable diseases and injuries. Differentiated cells produced from hES cells are being explored for their potential to treat a long list of ailments, including diabetes and age-related macular degeneration. It's going to take a combination of excellent tools and strong partnerships to further advance our understanding of these diseases and translate those learnings into new therapies.
Developing an hES cell-based therapy is a significant undertaking. It requires careful consideration of several factors, such as ethically obtaining high-quality, GMP-grade hES cells; scaling up the cell product to clinically relevant quantities; and following regional requirements and regulations. It also requires an understanding of the current and future hES cell therapy landscapes.
To illuminate some of the most important aspects that maximize the success of cell therapy development, we asked our experts to share their insights and best practices. Read on for their top 5 tips.
Would you like to learn more about the future landscape of embryonic stem cell research and cell-based therapies? Take a listen to an interview with our experts:
Takara Bio offers high-quality, innovative tools and stem cell services to help research groups accelerate translational and clinical discoveries. As a contract manufacturing organization (CMO), we offer comprehensive and seamless manufacturing and quality-testing services for cell and gene therapy products. We build trustworthy, long-term relationships with our customers and have a successful track record of creating products and processes used in a variety of life science research and clinical applications. Our experienced, dedicated team of scientists and business professionals will partner with you to provide customized solutions for your specific requirements. We look forward to working with you every step of the way, from initial consultation to final product delivery.
To inquire about clinical-grade hES cell derivation and other stem cell services, please fill out the form on the left. If you are on a mobile device, click on the hamburger icon () on the top left of your screen, and then scroll down to access the form.
Go CMO: guidelines for choosing a stem cell therapy manufacturing partner
Read about how to find a CMO partner for your downstream clinical cell therapy applications.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2023 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.
